920P The sarcopenia skeletal muscle mass index (SMI) has a three-tier survival effect in HNSCC, which can be predicted by hemoglobin (Hb), lymphocytes (Ly) and creatinine (Cre)

Volume: 32, Pages: S811 - S811
Published: Sep 1, 2021
Abstract
In cancer, sarcopenia is an important predictor of adverse outcome and treatment-related toxicity. SMI is an established surrogate of sarcopenia for advanced head and neck squamous cell carcinoma (aHNSCC) patients (pts). However, ideal cut-off values for prognostication and biochemical predictors of SMI are under reported for pts approaching a first-line...
Paper Details
Title
920P The sarcopenia skeletal muscle mass index (SMI) has a three-tier survival effect in HNSCC, which can be predicted by hemoglobin (Hb), lymphocytes (Ly) and creatinine (Cre)
Published Date
Sep 1, 2021
Volume
32
Pages
S811 - S811
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.